Cell
Volume 178, Issue 4, 8 August 2019, Pages 807-819.e21
ArticleThe Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
NRF2
FN3K
glycation
hepatocellular carcinoma
redox
EGFR
KEAP1
de-glycation
fructosamine
glucose
Cited by (0)
- 10
Lead Contact
- 11
Present address: Functional Genomics, Target Sciences and Technologies, Pfizer Inc., Pearl River, New York, USA
© 2019 Elsevier Inc.